Were Hedge Funds Right About Cardiovascular Systems Inc (CSII)?
In this article we will check out the progression of hedge fund sentiment towards Cardiovascular Systems Inc (NASDAQ:CSII) and determine whether it is a good investment right now.
Cardiovascular Systems Inc (CSII)
$20.00 +0.03 (+0.15%) Market is closed
News
- 1 - 10
- Next >>
Is CSII A Good Stock To Buy Now According To Hedge Funds?
In this article you are going to find out whether hedge funds think Cardiovascular Systems Inc (NASDAQ:CSII) is a good investment right now.
Hedge Funds Coming Back To Cardiovascular Systems Inc (CSII)
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...
Were Hedge Funds Right About Ditching Cardiovascular Systems Inc (CSII)?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Were Hedge Funds Right About Cardiovascular Systems Inc (CSII)?
We hate to say this but, we told you so.
Hedge Funds Are Dumping Cardiovascular Systems Inc (CSII)
How do we determine whether Cardiovascular Systems Inc (NASDAQ:CSII) makes for a good investment at the moment? We analyze the sentiment of a select group of the very best investors in the world, who ...
Is Cardiovascular Systems Inc (CSII) A Good Stock To Buy ?
Is Cardiovascular Systems Inc (NASDAQ:CSII) a good equity to bet on right now? We like to check what the smart money thinks first before doing extensive research on a given stock.
Is Cardiovascular Systems Inc (CSII) A Good Stock To Buy?
We at Insider Monkey have gone over 700 13F filings that hedge funds and prominent investors are required to file by the SEC.
Hedge Funds See Something to Like in Cardiovascular Systems Inc (CSII)
The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive database.
Healthcare-Focused Broadfin Capital's Notable Moves Include Cardiovascular Systems, Nevro Corp & Others
Kevin Kotler's healthcare-focused fund Broadfin Capital held a 13F portfolio valued at about $1.04 billion at the end of the first quarter, according to its latest filing.
- 1 - 10
- Next >>
Billionaire Hedge Funds
